Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

¸»±â ½ÅÁúȯ ȯÀÚ¿¡¼­ ½É±â´É ÁöÇ¥µéÀÇ Ç÷¾× Åõ¼®¿¡ µû¸¥ º¯È­ The changes in cardiac dimensions and function in patients with end stage renal disease undergoing hemodialysis

´ëÇѳ»°úÇÐȸÁö 2001³â 60±Ç 6È£ p.567 ~ 573
¼Ò¼Ó »ó¼¼Á¤º¸
À̵¿¿ø/Dong Won Lee ±è¿ë¹ü/¾È½ÂÀç/Á¤À¯¼®/°ûÀÓ¼ö/½Å¿µ¿ì/³ªÇÏ¿¬/Yong Beom Kim/Seoung Jae An/Yoo Suck Jung/Ihm Soo Kwak/Yung Woo Shin/Ha Youn Rha

Abstract

¸ñÀû : ¸»±â ½ÅÁúȯ ȯÀÚ¿¡¼­ Ç÷¾× Åõ¼®À» ½ÃÇàÇÔ¿¡ ÀÖ¾î ½ÉÀå ±â´É¿¡ ´ëÇÑ Æò°¡´Â ÇʼöÀûÀ̸ç, Ä¡·á È¿°úÀÇ ÆÇÁ¤°ú ÇâÈÄ Ä¡·á ¹æÇâÀÇ °áÁ¤¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÑ´Ù. µû¶ó¼­ Ç÷¾× Åõ¼® ¿ä¹ýÀ» ¹Þ°í ÀÖ´Â ¸»±â ½ÅÁúȯ ȯÀÚµéÀ» ´ë»óÀ¸·Î ½ÉÀåÀÇ ¿ëÀû º¯È­ ¹× Á½ɽÇ
¹ÚÃâ
°è¼ö
µîÀ» ÃøÁ¤, ºñ±³ÇÔÀ¸·Î¼­ Ç÷¾× Åõ¼®¿¡ µû¸¥ ½ÉÀå ±â´ÉÀÇ º¯È­¸¦ °üÂûÇÏ°íÀÚ ÇÏ¿´´Ù.
¹æ¹ý : 1997³â 2¿ùºÎÅÍ 1999³â 8¿ù±îÁö ºÎ»ê ´ëÇб³ º´¿ø Àΰø ½ÅÀå½Ç¿¡¼­ Ç÷¾× Åõ¼® ¿ä¹ýÀ» ¹Þ°í ÀÖ´Â 20¸íÀÇ ¸»±â ½ÅÁúȯ ȯÀÚµéÀ» ´ë»óÀ¸·Î ÇÏ¿© Ç÷¾× Åõ¼® ½ÃÀÛ½Ã¿Í ÃßÀû °üÂû ÈÄÀÇ ½ÉÃÊÀ½Æĸ¦ ½ÃÇàÇÏ¿© ½ÉÀåÀÇ ¿ëÀû ¹× ÁÂ½É½Ç ¹ÚÃâ °è¼ö¸¦ ÃøÁ¤, ºñ±³ÇÏ¿´À¸¸ç
gated
blood pool scintigraphy¸¦ ½ÃÇàÇÏ¿© ÁÂ½É½Ç ¹ÚÃâ °è¼ö ÃøÁ¤ÀÇ º¸Á¶ ¼ö´ÜÀ¸·Î ÀÌ¿ëÇÏ¿´´Ù. Paired t-test¸¦ ÀÌ¿ëÇÏ¿© Åë°èÀû À¯ÀǼºÀ» °ËÅäÇÏ¿´´Ù.
°á°ú : ´ë»ó ȯÀÚµéÀÇ Æò±Õ ¿¬·ÉÀº 46.2¡¾16.8¼¼¿´°í, ¿øÀÎ ÁúȯÀº ´ç´¢º´ 10 ¿¹, °íÇ÷¾Ð 7 ¿¹, »ç±¸Ã¼ ½Å¿° 2¿¹ µîÀ̾ú°í, º´¹ßÇÑ ½ÉÇ÷°ü ÇÕº´ÁõÀº °íÇ÷¾Ð 20 ¿¹, °íÇ÷¾Ð¼º ½ÉÁúȯ 7 ¿¹, ¿ïÇ÷¼º ½ÉºÎÀü 7¿¹, È®À强 ½É±Ùº´Áõ 4¿¹, ½ÉÀå ÆǸ· Áúȯ 2 ¿¹, ÇãÇ÷¼º
½ÉÁúȯ 1
¿¹ µîÀ̾ú´Ù. ½ÅºÎÀüÀÇ Áõ»ó ¹ßÇö¿¡¼­ Ç÷¾× Åõ¼® ½ÃÀÛ ½Ã±îÁöÀÇ ±â°£Àº Æò±Õ 3.4¡¾2.6³âÀ̾ú°í, Ç÷¾× Åõ¼® ½ÃÀÛ ÈÄ ÃßÀû °üÂû ±â°£Àº Æò±Õ 13.8¡¾7.0°³¿ùÀ̾ú´Ù.
Àü¹ÝÀûÀ¸·Î LVEDID, LVESID, RVC µîÀº °¢°¢ -6.10%, -7.80%, -20.00%ÀÇ ÀÇ¹Ì ÀÖ´Â ¿ëÀû °¨¼Ò (p<0.05)¸¦ º¸ÀÎ ¹Ý¸é. LAD, IVS, PWT, EF µî¿¡¼­´Â À¯ÀÇÇÑ º¯È­°¡ ¾ø¾ú´Ù (p> 0.05). ´ç´¢º´ÀÌ ÀÖ¾ú´ø 10¿¹¿¡¼­´Â LVEDID°¡ -7.90%ÀÇ ÀÇ¹Ì ÀÖ´Â Åõ¼® ÈÄ ¿ëÀû °¨¼Ò¸¦
º¸¿´°í
(p<0.05), LAD, LVESID, IVS, PWT,
RVC, EF µî¿¡¼­´Â À¯ÀÇÇÑ º¯È­°¡ ¾ø¾ú´Ù (p>0.05). ½ÉÀå ÁúȯÀÌ ÀÖ¾ú´ø 12¿¹¿¡¼­´Â LVEDID, LVESID µîÀÌ °¢°¢ -8.60, -10.50%ÀÇ ÀÇ¹Ì ÀÖ´Â °¨¼Ò ¼Ò°ßÀ» º¸¿´À¸³ª (p<0.05), LAD, IVS, PWT, RVC, EF µî¿¡¼­´Â À¯ÀÇÇÑ º¯È­°¡ ¾ø¾ú´Ù (p>0.05). ½ÉÀå Áúȯ ¾øÀÌ
´ç´¢º´¸¸
ÀÖ¾ú´ø 4¿¹¿¡¼­´Â LAD°¡ -5.10%ÀÇ ÀÇ¹Ì ÀÖ´Â °¨¼Ò¸¦ º¸¿´À¸³ª (p<0.05), ´ç´¢º´ ¾øÀÌ ½ÉÀå Áúȯ¸¸ ÀÖ¾ú´ø 4¿¹¿¡¼­´Â À¯ÀÇÇÑ º¯È­°¡ ¾ø¾ú´Ù (p>0.05). ´ç´¢º´°ú ½ÉÀå ÁúȯÀÌ µ¿¹ÝµÇ¾î ÀÖ´Â 7¿¹¿¡¼­´Â LVEDID°¡ -10.50%ÀÇ ÀÇ¹Ì ÀÖ´Â °¨¼Ò¸¦ º¸¿´´Ù (p<0.05). Gated
blood
pool image (RVG)¸¦ ÀÌ¿ëÇÏ¿© ÃøÁ¤ÇÑ EF¿¡¼­´Â -0.90%ÀÇ °¨¼Ò¸¦ º¸¿´´Ù (p<0.05). ±×·¯³ª ´ç´¢º´°ú ½ÉÀåÁúȯÀÌ µ¿¹ÝµÈ °æ¿ì¿£ 5.90%ÀÇ ÀÇ¹Ì ÀÖ´Â Áõ°¡¸¦ º¸¿´´Ù (p<0.05).
°á·Ð : ¸»±â ½ÅÁúȯÀÇ Ç÷¾× Åõ¼® Ãʱ⿡´Â ±¸½É¼º ÁÂ½É½Ç ºñ´ë ¼Ò°ßÀ» º¸¿´À¸³ª ÁÂ½É½Ç ±â´ÉÀº ºñ±³Àû Àß À¯ÁöµÇ¾ú´Ù. ÇâÈÄ Ç÷¾× Åõ¼®À» ÅëÇØ °ÇÁ¶Ã¼ÁßÀ» °¡´ÉÇÑ ÇÑ ³·°Ô À¯ÁöÇÔÀ¸·Î½á ¿ø½É¼º ÁÂ½É½Ç ºñ´ë, È®À强 ½É±Ù º´ÁõÀ¸·ÎÀÇ ÁøÇàÀ» ¿¹¹æÇÒ ¼ö ÀÖÀ» °ÍÀ¸·Î
±â´ëµÈ´Ù.

Background : It is absolutely necessary to evaluate cardiac function at starting and during hemodialysis in patients with end stage renal disease. In this study, we tried to determinate the changes of cardiac function associated with
hemodialysis.
Methods : Twenty patients with end stage renal disease were enrolled , who had been in hemodialysis program from February, 1997 to August, 1999 in Pusan National University Hospital. They were examined with echocardiography and gated blood pool
scintigraphy at starting hemodialysis and after follow-up. The data were analyzed by paired T-test.
Results : The patients were 46.2¡¾16.8 years old and male to female ratio was 8 : 12. The underlying diseases were diabetes mellitus(n=10), hypertension(7), glomerulonephritis (2) and others(1). The duration of symptoms associated with end stage
renal
dis- ease and underlying diseases was 3.4¡¾2.6 years, and the duration of hemodialysis was 13.8¡¾7.0 months. The LVEDID, LVESID and RVC decreased significantly (-6.10, -7.80 and -20.00%, respectively, p<0.05) with no significant changes for LAD,
IVS,
PWT and EF (p>0.05). In ten cases associated with diabetes, LVEDID decreased (-7.90%, p<0.05). In twelve cases associated with cardiac diseases, LVEDID and LVESID decreased (-8.60 and -10.50%, respectively, p<0.05). In four cases associated with
diabetes without cardiac diseases, LAD decreased (-5.10%, p<0.05). And in four cases associated with cardiac diseases without diabetes, there were no significant changes in cardiac dimensions and EF. In seven cases associated with diabetes and
cardiac
diseases, LVEDID decreased (-10.50%, p<0.05). The EF on gated blood pool scintigraphy decreased (-0.9%, p<0.05) as a whole, while increased (5.90%, p<0.05) in the cases associated with diabetes and cardiac diseases.
Conclusion : During the early hemodialysis stage of end stage renal disease, we found a change of concentric left ventricular hypertrophy and relatively preserved left ventricular function. Furthermore we can expect that adequate hemodialysis
-with
dry-weight as low as possible - may prevent progression to eccentric left ventricular hypertrophy and dilated cadiomyopathy.

Å°¿öµå

End stage renal disease; Hemodialysis; Echocardiography; Cardiac function;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS